Patient characteristics
Age, y median (range) | 61 (38-77) |
| Clinical stage, % | |
| IA | 0 |
| IB | 0 |
| IIA | 5 |
| IIB | 9 |
| IIIA | 27 |
| IIIB | 18 |
| IVA | 32 |
| IVB | 9 |
| WHO performance status, % | |
| 0 | 22 |
| 1 | 55 |
| 2 | 23 |
| B-symptoms, % | |
| Yes | 36 |
| No | 64 |
| No. previous regimens, median (range) | 3 (1-5) |
| Itching according to VAS*, median (range) | 8 (1-10) |
Age, y median (range) | 61 (38-77) |
| Clinical stage, % | |
| IA | 0 |
| IB | 0 |
| IIA | 5 |
| IIB | 9 |
| IIIA | 27 |
| IIIB | 18 |
| IVA | 32 |
| IVB | 9 |
| WHO performance status, % | |
| 0 | 22 |
| 1 | 55 |
| 2 | 23 |
| B-symptoms, % | |
| Yes | 36 |
| No | 64 |
| No. previous regimens, median (range) | 3 (1-5) |
| Itching according to VAS*, median (range) | 8 (1-10) |
Total number of patients was 22.
n = 17 patients with itching.